For instance, FoxA3 was described as a potent tumor suppressor in CRC, which may disrupt the maintenance of stemness and modulate the sensitivity to oxaliplatin by inhibiting the transcription of MACC1 [130]. This evidence concerns the gene MACC1 and neoplasm.